用于实验性治疗厌食症的 Acyl-CoA 结合蛋白。

IF 15.8 1区 医学 Q1 CELL BIOLOGY Science Translational Medicine Pub Date : 2024-08-14 DOI:10.1126/scitranslmed.adl0715
Hui Chen, Stéphanie Moriceau, Adrien Joseph, Francois Mailliet, Sijing Li, Virginie Tolle, Philibert Duriez, Roland Dardennes, Sylvère Durand, Vincent Carbonnier, Gautier Stoll, Allan Sauvat, Sylvie Lachkar, Fanny Aprahamian, Carolina Alves Costa Silva, Hui Pan, Léa Montégut, Gerasimos Anagnostopoulos, Flavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde, Mélanie Bourgin, Misha Mao, Yuhong Pan, Alexandra Cerone, Erwan Boedec, Zelia L. Gouveia, Federica Marmorino, Chiara Cremolini, Lisa Derosa, Laurence Zitvogel, Oliver Kepp, Carlos López-Otín, Maria Chiara Maiuri, Franck Perez, Philip Gorwood, Nicolas Ramoz, Franck Oury, Isabelle Martins, Guido Kroemer
{"title":"用于实验性治疗厌食症的 Acyl-CoA 结合蛋白。","authors":"Hui Chen,&nbsp;Stéphanie Moriceau,&nbsp;Adrien Joseph,&nbsp;Francois Mailliet,&nbsp;Sijing Li,&nbsp;Virginie Tolle,&nbsp;Philibert Duriez,&nbsp;Roland Dardennes,&nbsp;Sylvère Durand,&nbsp;Vincent Carbonnier,&nbsp;Gautier Stoll,&nbsp;Allan Sauvat,&nbsp;Sylvie Lachkar,&nbsp;Fanny Aprahamian,&nbsp;Carolina Alves Costa Silva,&nbsp;Hui Pan,&nbsp;Léa Montégut,&nbsp;Gerasimos Anagnostopoulos,&nbsp;Flavia Lambertucci,&nbsp;Omar Motiño,&nbsp;Uxía Nogueira-Recalde,&nbsp;Mélanie Bourgin,&nbsp;Misha Mao,&nbsp;Yuhong Pan,&nbsp;Alexandra Cerone,&nbsp;Erwan Boedec,&nbsp;Zelia L. Gouveia,&nbsp;Federica Marmorino,&nbsp;Chiara Cremolini,&nbsp;Lisa Derosa,&nbsp;Laurence Zitvogel,&nbsp;Oliver Kepp,&nbsp;Carlos López-Otín,&nbsp;Maria Chiara Maiuri,&nbsp;Franck Perez,&nbsp;Philip Gorwood,&nbsp;Nicolas Ramoz,&nbsp;Franck Oury,&nbsp;Isabelle Martins,&nbsp;Guido Kroemer","doi":"10.1126/scitranslmed.adl0715","DOIUrl":null,"url":null,"abstract":"<div >Extracellular acyl-coenzyme A binding protein [ACBP encoded by diazepam binding inhibitor (DBI)] is a phylogenetically ancient appetite stimulator that is secreted in a nonconventional, autophagy-dependent fashion. Here, we show that low ACBP/DBI plasma concentrations are associated with poor prognosis in patients with anorexia nervosa, a frequent and often intractable eating disorder. In mice, anorexia induced by chronic restraint stress (CRS) is accompanied by a reduction in circulating ACBP/DBI concentrations. We engineered a chemical-genetic system for the secretion of ACBP/DBI through a biotin-activatable, autophagy-independent pathway. In transgenic mice expressing this system in hepatocytes, biotin-induced elevations in plasma ACBP/DBI concentrations prevented anorexia induced by CRS or chemotherapeutic agents including cisplatin, doxorubicin, and paclitaxel. ACBP/DBI reversed the CRS or cisplatin-induced increase in plasma lipocalin-2 concentrations and the hypothalamic activation of anorexigenic melanocortin 4 receptors, for which lipocalin-2 is an agonist. Daily intravenous injections of recombinant ACBP/DBI protein or subcutaneous implantation of osmotic pumps releasing recombinant ACBP/DBI mimicked the orexigenic effects of the chemical-genetic system. In conclusion, the supplementation of extracellular and peripheral ACBP/DBI might constitute a viable strategy for treating anorexia.</div>","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"16 760","pages":""},"PeriodicalIF":15.8000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.science.org/doi/reader/10.1126/scitranslmed.adl0715","citationCount":"0","resultStr":"{\"title\":\"Acyl-CoA binding protein for the experimental treatment of anorexia\",\"authors\":\"Hui Chen,&nbsp;Stéphanie Moriceau,&nbsp;Adrien Joseph,&nbsp;Francois Mailliet,&nbsp;Sijing Li,&nbsp;Virginie Tolle,&nbsp;Philibert Duriez,&nbsp;Roland Dardennes,&nbsp;Sylvère Durand,&nbsp;Vincent Carbonnier,&nbsp;Gautier Stoll,&nbsp;Allan Sauvat,&nbsp;Sylvie Lachkar,&nbsp;Fanny Aprahamian,&nbsp;Carolina Alves Costa Silva,&nbsp;Hui Pan,&nbsp;Léa Montégut,&nbsp;Gerasimos Anagnostopoulos,&nbsp;Flavia Lambertucci,&nbsp;Omar Motiño,&nbsp;Uxía Nogueira-Recalde,&nbsp;Mélanie Bourgin,&nbsp;Misha Mao,&nbsp;Yuhong Pan,&nbsp;Alexandra Cerone,&nbsp;Erwan Boedec,&nbsp;Zelia L. Gouveia,&nbsp;Federica Marmorino,&nbsp;Chiara Cremolini,&nbsp;Lisa Derosa,&nbsp;Laurence Zitvogel,&nbsp;Oliver Kepp,&nbsp;Carlos López-Otín,&nbsp;Maria Chiara Maiuri,&nbsp;Franck Perez,&nbsp;Philip Gorwood,&nbsp;Nicolas Ramoz,&nbsp;Franck Oury,&nbsp;Isabelle Martins,&nbsp;Guido Kroemer\",\"doi\":\"10.1126/scitranslmed.adl0715\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div >Extracellular acyl-coenzyme A binding protein [ACBP encoded by diazepam binding inhibitor (DBI)] is a phylogenetically ancient appetite stimulator that is secreted in a nonconventional, autophagy-dependent fashion. Here, we show that low ACBP/DBI plasma concentrations are associated with poor prognosis in patients with anorexia nervosa, a frequent and often intractable eating disorder. In mice, anorexia induced by chronic restraint stress (CRS) is accompanied by a reduction in circulating ACBP/DBI concentrations. We engineered a chemical-genetic system for the secretion of ACBP/DBI through a biotin-activatable, autophagy-independent pathway. In transgenic mice expressing this system in hepatocytes, biotin-induced elevations in plasma ACBP/DBI concentrations prevented anorexia induced by CRS or chemotherapeutic agents including cisplatin, doxorubicin, and paclitaxel. ACBP/DBI reversed the CRS or cisplatin-induced increase in plasma lipocalin-2 concentrations and the hypothalamic activation of anorexigenic melanocortin 4 receptors, for which lipocalin-2 is an agonist. Daily intravenous injections of recombinant ACBP/DBI protein or subcutaneous implantation of osmotic pumps releasing recombinant ACBP/DBI mimicked the orexigenic effects of the chemical-genetic system. In conclusion, the supplementation of extracellular and peripheral ACBP/DBI might constitute a viable strategy for treating anorexia.</div>\",\"PeriodicalId\":21580,\"journal\":{\"name\":\"Science Translational Medicine\",\"volume\":\"16 760\",\"pages\":\"\"},\"PeriodicalIF\":15.8000,\"publicationDate\":\"2024-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.science.org/doi/reader/10.1126/scitranslmed.adl0715\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Science Translational Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.science.org/doi/10.1126/scitranslmed.adl0715\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/scitranslmed.adl0715","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

细胞外酰基辅酶 A 结合蛋白[ACBP,由地西泮结合抑制剂(DBI)编码]是一种系统发育古老的食欲刺激物,它以一种非常规的、依赖于自噬的方式分泌。在这里,我们发现低 ACBP/DBI 血浆浓度与神经性厌食症患者的不良预后有关,神经性厌食症是一种常见的、往往难以治愈的进食障碍。在小鼠中,慢性束缚应激(CRS)诱发的厌食症伴随着循环 ACBP/DBI 浓度的降低。我们设计了一个化学遗传系统,通过生物素激活的、不依赖自噬的途径分泌 ACBP/DBI。在肝细胞中表达该系统的转基因小鼠中,生物素诱导的血浆 ACBP/DBI 浓度升高可防止 CRS 或包括顺铂、多柔比星和紫杉醇在内的化疗药物诱导的厌食症。ACBP/DBI 逆转了 CRS 或顺铂诱导的血浆脂褐素-2 浓度的增加,以及下丘脑对厌食性黑皮素 4 受体的激活,而脂褐素-2 是黑皮素 4 受体的一种激动剂。每天静脉注射重组 ACBP/DBI 蛋白或皮下注射释放重组 ACBP/DBI 的渗透泵可模拟化学遗传系统的促厌食效应。总之,补充细胞外和外周 ACBP/DBI 可能是治疗厌食症的一种可行策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Acyl-CoA binding protein for the experimental treatment of anorexia
Extracellular acyl-coenzyme A binding protein [ACBP encoded by diazepam binding inhibitor (DBI)] is a phylogenetically ancient appetite stimulator that is secreted in a nonconventional, autophagy-dependent fashion. Here, we show that low ACBP/DBI plasma concentrations are associated with poor prognosis in patients with anorexia nervosa, a frequent and often intractable eating disorder. In mice, anorexia induced by chronic restraint stress (CRS) is accompanied by a reduction in circulating ACBP/DBI concentrations. We engineered a chemical-genetic system for the secretion of ACBP/DBI through a biotin-activatable, autophagy-independent pathway. In transgenic mice expressing this system in hepatocytes, biotin-induced elevations in plasma ACBP/DBI concentrations prevented anorexia induced by CRS or chemotherapeutic agents including cisplatin, doxorubicin, and paclitaxel. ACBP/DBI reversed the CRS or cisplatin-induced increase in plasma lipocalin-2 concentrations and the hypothalamic activation of anorexigenic melanocortin 4 receptors, for which lipocalin-2 is an agonist. Daily intravenous injections of recombinant ACBP/DBI protein or subcutaneous implantation of osmotic pumps releasing recombinant ACBP/DBI mimicked the orexigenic effects of the chemical-genetic system. In conclusion, the supplementation of extracellular and peripheral ACBP/DBI might constitute a viable strategy for treating anorexia.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Science Translational Medicine
Science Translational Medicine CELL BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
26.70
自引率
1.20%
发文量
309
审稿时长
1.7 months
期刊介绍: Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research. The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases. The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine. The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.
期刊最新文献
Disrupting the RNA polymerase II transcription cycle through CDK7 inhibition ameliorates inflammatory arthritis NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer Delayed low-dose oral administration of 4′-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease Vagal stimulation ameliorates murine colitis by regulating SUMOylation Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1